Corrigendum to “The second nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan” [J. Infect. Chemother. 29 (2023) 143–149, (S1341321X22002884), (10.1016/j.jiac.2022.10.005)]

Takamitsu Ohnishi*, Shinichi Watanabe, Tetsuya Matsumoto, Hiroshi Yotsuyanagi, Junko Sato, Intestu Kobayashi, Shin Iinuma, Takashi Nagayama, Shuichiro Shibuya, Natsuki Ogawa, Ken Iozumi, Yasuyuki Nakajima, Yukiko Kurikawa, Motoko Kobayashi, Koma Matsuo, Hideyuki Ishikawa, Tadamichi Shimizu, Kiyohiro Tsutsui, Tatsuyoshi Kawamura, Ryuhei OkuyamaMariko Seishima, Yoichi Akita, Chikatoshi Kasugai, Katsuaki Yano, Yasuhiko Tamada, Kimihiko Mizutani, Kenji Kabashima, Nanako Yamada, Masami Ikeda

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors would like to correct the funding. Funding This study was supported by grants from the following pharmaceutical companies (in alphabetical order): Astellas Pharma Inc., Choseido Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Daiichi-Sankyo Espha Co., Ltd., Fujifilm Toyama Chemical Co., Ltd., GlaxoSmithKline. K.K., Kobayashi Kako Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd., Nichi-Iko Pharmaceutical Co., Ltd., Nipro Corporation., Ohara Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sawai Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takata Pharmaceutical Co., Ltd., Teva Takeda Pharma Ltd., Towa Pharmaceutical Co., Ltd., and Yoshindo Inc.

Original languageEnglish
Pages (from-to)634-635
Number of pages2
JournalJournal of Infection and Chemotherapy
Volume29
Issue number6
DOIs
StatePublished - 2023/06

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Corrigendum to “The second nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan” [J. Infect. Chemother. 29 (2023) 143–149, (S1341321X22002884), (10.1016/j.jiac.2022.10.005)]'. Together they form a unique fingerprint.

Cite this